Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-27
1996-06-18
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 31435, C07D47104
Patent
active
055278094
ABSTRACT:
Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active compounds in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.
REFERENCES:
patent: 5128355 (1992-07-01), Carini et al.
patent: 5138069 (1992-08-01), Carini et al.
patent: 5153197 (1992-10-01), Carini et al.
patent: 5155118 (1992-10-01), Carini et al.
patent: 5240938 (1993-08-01), Greenlee
Chemical Abstracts 118:191734 of DE 4200954 published 29 Oct. 1992, 1992.
Chemical Abstracts 118:234063 of EP 513533 published 19 Nov. 1992, 1992.
The Journal of Cell Biology, vol. 50, 1971, pp. 172-186; "The Smooth Muscle Cell", R. Ross.
Beuck Martin
Dressel Jurgen
Fey Peter
Hanko Rudolf H.
Hubsch Walter
Bayer Aktiengesellschaft
Gerstenzang William C.
Ivy C. Warren
M. Mach D. Margaret
LandOfFree
Substituted imidazo[4,5-b]pyridines and benzimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazo[4,5-b]pyridines and benzimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazo[4,5-b]pyridines and benzimidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-223156